The DOI matches its Crossref record.
FUMAGILLIN TREATMENT OF INTESTINAL MICROSPORIDIOSIS
Abstract
FUMAGILLIN TREATMENT OF INTESTINAL MICROSPORIDIOSIS [Molina J-M et al. NEJM 2002;346:1963]: This is a report from the National Agency of Research of SIDA 090 Study Group in France consisting of a randomized, double-blind, placebo-controlled trial of fumagillin (60 mg/day for two weeks) for 12 patients with chronic microsporidiosis caused by E. bieneusi. There were 10 patients with HIV infection and two organ transplant recipients. All six of the patients treated with fumagillin had clearance of microsporidia, and this treatment was associated with improved median values for absorption of D-xylose, Karnofsky performance scores, decrease in loperamide use, and a stool weight. Of the six, three developed thrombocytopenia. Two of the six fumagillin recipients had relapses during a median follow-up period of ten months. These results are summarized in Table 2.TABLE 2Comment: Fumagillin is an antibiotic derived from Aspergillus fumagitus and has been used to treat microsporidiosis in honeybees [Science 1952;115:70] and topically to treat ocular microsporidiosis in humans. Its potential use for microsporidiosis intestinal infection due to E. bieneusi is most welcome. The only alternative antimicrobial used with any success is albendazole, which appears active only in the minority of cases caused by E. intestinalis. The preferred treatment has and will continue to be HAART, but there are obviously some patients who could benefit from fumagillin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Zoonotic Potential of the Microsporidia
Mathis, A., Weber, R., & Deplazes, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.423-445.2005 · Cited by 474
Enteric Protozoa in the Developed World: a Public Health Perspective
Fletcher, S. M., Stark, D., Harkness, J., & Ellis, J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05038-11 · Cited by 434
Biosynthesis of fungal meroterpenoids
Matsuda, Y., & Abe, I. (2016) · Natural Product Reports · doi:10.1039/c5np00090d · Cited by 429
Microsporidiosis: current status
Didier, E. S., & Weiss, L. M. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000244055.46382.23 · Cited by 393
Metadata
- Authors
- &NA;
- Venue
- Infectious Diseases in Clinical Practice
- Published
- 2002-03
- Volume
- 11
- Issue
- 3
- Pages
- 176-177
- ISSN
- 1056-9103 (ISSN-L)
- OpenAlex
- W4249091668
- Cited by
- 171
- References
- 0
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FUMAGILLIN TREATMENT OF INTESTINAL MICROSPORIDIOSIS. https://app.cochat.ai/papers/10.1097/00019048-200203000-00039
- The paper
- &NA;. (2002). FUMAGILLIN TREATMENT OF INTESTINAL MICROSPORIDIOSIS. Infectious Diseases in Clinical Practice. https://doi.org/10.1097/00019048-200203000-00039
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.